Anne-Laure Morel, founding president of Torskal, Ph.D. in the physical chemistry of materials and a master’s degree in structural biochemistry, specifies that these unprecedented trials will be conducted at the Clinique Sainte-Clotilde (CSC), in association with Drs. Mickaël Bègue and Youssef Slama, respectively radiation oncologist and head of the radiophysics unit at the CSC, and Antoine Bertolotti, dermatologist at the CHU de Saint-Pierre. In metropolitan France, parallel clinical trials will be conducted in collaboration with a public hospital.
According to Torskal, in Reunion Island, where the UV index is high all year round, the incidence rate of cutaneous melanoma is equivalent to that found in Australia. Every year, about a hundred new cases are recorded. The number of these skin cancers has multiplied by 5 in 10 years.
Article and video credit: Réunion la 1ère